Last Updated: May 10, 2026

List of Excipients in API ursodiol


✉ Email this page to a colleague

« Back to Dashboard


Excipients in NDA-approved (novel) drugs containing ursodiol

Glossary
Company Tradename Ingredient NDC Excipient Potential Generic Entry
Actavis Pharma Inc URSODIOL ursodiol 0591-2998 CARNAUBA WAX
Actavis Pharma Inc URSODIOL ursodiol 0591-2998 CELLULOSE, MICROCRYSTALLINE
Actavis Pharma Inc URSODIOL ursodiol 0591-2998 CETYL ALCOHOL
Actavis Pharma Inc URSODIOL ursodiol 0591-2998 DIBUTYL SEBACATE
Actavis Pharma Inc URSODIOL ursodiol 0591-2998 ETHYLCELLULOSE
Actavis Pharma Inc URSODIOL ursodiol 0591-2998 HYDROGEN PEROXIDE
Actavis Pharma Inc URSODIOL ursodiol 0591-2998 HYPROMELLOSE
>Company >Tradename >Ingredient >NDC >Excipient >Potential Generic Entry

Subscribe to access the full database, or Start Trial

Excipients in ANDA-approved (generic) drugs containing ursodiol

Company Ingredient NDC Excipient
Mylan Pharmaceuticals Inc ursodiol 0378-1730 CELLULOSE, MICROCRYSTALLINE
Mylan Pharmaceuticals Inc ursodiol 0378-1730 D&C YELLOW NO. 10
Mylan Pharmaceuticals Inc ursodiol 0378-1730 FD&C BLUE NO. 1
Mylan Pharmaceuticals Inc ursodiol 0378-1730 FD&C BLUE NO. 2
Mylan Pharmaceuticals Inc ursodiol 0378-1730 FD&C RED NO. 40
Mylan Pharmaceuticals Inc ursodiol 0378-1730 FD&C YELLOW NO. 6
Mylan Pharmaceuticals Inc ursodiol 0378-1730 FERROSOFERRIC OXIDE
>Company >Ingredient >NDC >Excipient

Subscribe to access the full database, or Start Trial

Detailed excipient profiles for ursodiol

Excipient focus: ALCOHOL

Excipient focus: ALUMINUM OXIDE

Excipient focus: AMMONIA

Excipient focus: BUTYL ALCOHOL

Excipient focus: CARNAUBA WAX

Excipient focus: CELLULOSE, MICROCRYSTALLINE

Excipient focus: CETYL ALCOHOL

Excipient focus: COLLOIDAL SILICON DIOXIDE

Excipient focus: COPOVIDONE

Excipient focus: COPOVIDONE K25-31

Excipient focus: D&C RED NO. 28

Excipient focus: D&C YELLOW NO. 10

Excipient focus: D&C YELLOW NO. 10 ALUMINUM LAKE

Excipient focus: DIBUTYL SEBACATE

Excipient focus: ETHYLCELLULOSE

Excipient focus: FD&C BLUE NO. 1

Excipient focus: FD&C BLUE NO. 1 ALUMINUM LAKE

Excipient focus: FD&C BLUE NO. 2

Excipient focus: FD&C BLUE NO. 2 ALUMINUM LAKE

Excipient focus: FD&C RED NO. 3

Excipient focus: FD&C RED NO. 40

Excipient focus: FD&C RED NO. 40 ALUMINUM LAKE

Excipient focus: FD&C YELLOW NO. 6

Excipient focus: FERRIC OXIDE

Excipient focus: FERRIC OXIDE RED

Excipient focus: FERRIC OXIDE YELLOW

Excipient focus: FERROSOFERRIC OXIDE

Excipient focus: GELATIN

Excipient focus: HYDROGEN PEROXIDE

Excipient focus: HYDROXYPROPYL CELLULOSE

Excipient focus: HYPROMELLOSE

Excipient focus: HYPROMELLOSE 2910

Excipient focus: HYPROMELLOSES

Excipient focus: ISOPROPYL ALCOHOL

Excipient focus: LACTOSE MONOHYDRATE

Excipient focus: MAGNESIUM STEARATE

Excipient focus: MEDIUM-CHAIN TRIGLYCERIDES

Excipient focus: METHYL ALCOHOL

Excipient focus: POLYDEXTROSE

Excipient focus: POLYETHYLENE GLYCOL 3350

Excipient focus: POLYETHYLENE GLYCOL 400

Excipient focus: POLYETHYLENE GLYCOL 8000

Excipient focus: POTASSIUM HYDROXIDE

Excipient focus: POVIDONE

Excipient focus: POVIDONE K29/32

Excipient focus: POVIDONE K30

Excipient focus: PROPYLENE GLYCOL

Excipient focus: SHELLAC

Excipient focus: SILICON DIOXIDE

Excipient focus: SODIUM LAURYL SULFATE

Excipient focus: SODIUM STARCH GLYCOLATE TYPE A

Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO

Excipient focus: STARCH, CORN

Excipient focus: TALC

Excipient focus: TITANIUM DIOXIDE

Excipient focus: TROMETHAMINE

Excipient focus: WATER

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2026 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2026 - 2027
 NCE-1 Patent Challenge Dates 2026 - 2027
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2026, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links